Jeffrey Wade
Pharmacy benefit managers (PBMs) are entities that administer prescription drug insurance benefits. They are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. PBMs are paid an administrative fee by insurers for their services, but they also generate revenue by acquiring rebates from drug manufacturers and retaining a portion of the payment rates set for insurers and pharmacies. While PBMs claim to reduce costs for patients, critics argue that the system lacks transparency and may drive up drug prices. Insurers and their PBMs decide which medicines are covered and how much patients pay for them, often shifting healthcare costs onto patients through high deductibles and co-insurance. As a result, there is bipartisan interest in reforming the PBM business model.
| Characteristics | Values |
|---|---|
| Role | Pharmacy Benefit Managers (PBMs) act as middlemen between insurance plans, drug manufacturers, and pharmacies. |
| Functions | Negotiating prices with drug manufacturers and pharmacies, establishing drug formularies and pharmacy networks, and processing drug claims. |
| Impact on Drug Costs | PBMs can drive up prescription drug costs for insurers and consumers by engaging in practices such as spread pricing and retaining rebates. |
| Industry Influence | The three largest PBMs manage approximately 79%-80% of all prescription drugs in the US. |
| Regulatory Environment | There have been recent efforts to increase transparency and regulation of PBMs, including legislative proposals and the establishment of working groups to address prescription drug coverage issues. |
Explore related products
What You'll Learn
Pharmacy benefit managers (PBMs) are pharmaceutical middlemen
PBMs create and update formularies of preferred drugs, with different prices and cost-sharing amounts that influence what beneficiaries pay out of pocket and which medications they can access through their insurance. They negotiate rebates and discounts for an insurance plan from drug manufacturers and determine the prices insurers pay and the payments pharmacies receive. PBMs can also take on the administrative role of directly reimbursing retail pharmacies on behalf of an insurer.
PBMs are often behind-the-scenes players in the U.S. healthcare system. However, they hold significant influence over which medications patients receive, where they get them, and how much they pay. This makes them central players in the broader debate over prescription drug costs in the U.S.
While PBMs claim to reduce costs for patients and plan sponsors through these negotiations, critics argue that the system lacks transparency and may drive up drug prices. For instance, PBMs sometimes keep a portion of the rebates they negotiate rather than passing the full amount to insurers or patients. They may also engage in "spread pricing," where they charge a health plan more for a drug than they reimburse the pharmacy, pocketing the difference.
Insurers often pay an administrative fee to PBMs for their services. However, PBMs frequently generate additional revenue by acquiring rebates from drug manufacturers and retaining a portion of the payment rates they set for insurers and retail pharmacies. This practice can drive up costs for patients and insurers.
Esurance Life Insurance: What You Need to Know
You may want to see also
Explore related products
PBMs negotiate prices with drug manufacturers and pharmacies
Pharmacy Benefit Managers (PBMs) are pharmaceutical middlemen that occupy a central role in the drug price supply chain. They act as intermediaries between insurance plans, drug manufacturers, and pharmacies. The three largest PBMs, CVS Caremark, Express Scripts, and OptumRx, process approximately 79% of all prescription drugs in the United States.
PBMs also have the power to determine patients' access to different medications and can direct patients to specific pharmacies, including those they own. This influence has led to concerns about anti-competitive practices and the need for increased transparency in the PBM market.
While PBMs claim to reduce costs through negotiations, critics argue that their practices may drive up drug prices. For example, PBMs may engage in spread pricing, restrict access to lower-cost medications, or prioritize high-rebate medications over more affordable alternatives. These practices have drawn scrutiny from legislators and researchers, who are calling for legislative reforms to increase transparency and protect patients' access to affordable medications.
In summary, PBMs play a crucial role in negotiating prices with drug manufacturers and pharmacies, but their practices have come under scrutiny for their potential impact on drug prices and patient access to medications.
Life Insurance and Your Mortgage: When to Get Covered
You may want to see also
Explore related products
PBMs establish drug formularies and networks
Pharmacy benefit managers (PBMs) are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. They are negotiators, administrators, and decision-makers about which drugs will be most accessible to consumers. PBMs act as intermediaries between insurance plans, drug manufacturers, and pharmacies, working to control drug spending, process prescription claims, and determine which medications are covered by insurance plans.
One of the key responsibilities of PBMs is developing and maintaining formularies—lists of drugs that are covered under a given insurance plan. They negotiate with drug manufacturers to secure rebates and discounts in exchange for placing certain drugs in favourable positions on these formularies. The formulary is usually divided into several "tiers" of preference, with low tiers being assigned a higher copayment to incentivize consumers to buy drugs on a preferred tier. Drugs that do not appear on the formulary mean consumers must pay the full list price. To get drugs listed on the formulary, manufacturers are usually required to pay the PBM a manufacturer's rebate, which lowers the net price of the drug while keeping the list price the same.
PBMs also create networks by contracting with pharmacies to participate in networks managed by the PBMs, setting reimbursement terms for drugs dispensed to patients, and processing pharmacy claims for prescription drugs. PBMs' ability to negotiate manufacturer rebates and manage formularies to promote cost-effectiveness should, in theory, help to control growth in drug prices and patient spending over time.
However, there is controversy surrounding PBM practices, with critics arguing that the system lacks transparency and may drive up drug prices. For instance, PBMs sometimes keep a portion of the rebates they negotiate rather than passing the full amount to insurers or patients. They may also engage in "spread pricing," where they charge a health plan more for a drug than they reimburse the pharmacy, pocketing the difference. This has led to lawsuits and bipartisan criticism for unfair business practices.
Life Insurance: Your Unsung Asset Hero
You may want to see also
PBMs process drug claims
Pharmacy benefit managers (PBMs) are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. They occupy a central role in the drug price supply chain as negotiators, administrators, and decision-makers about which drugs will be most accessible to consumers. PBMs are not insurance companies, but they work closely with them and other payers to manage prescription drug benefits and control drug spending.
PBMs act as middlemen between insurance plans, drug manufacturers, and pharmacies. They work with insurance companies to determine which medicines are covered by insurance plans and what patients pay for them. PBMs negotiate with drug manufacturers to secure rebates and discounts in exchange for placing certain drugs in favourable positions on their formularies. They also contract with pharmacies to create pharmacy networks and determine how much those pharmacies will be paid for dispensing medications.
PBMs offer core services such as claims processing, record-keeping, and reporting programs. They also provide drug utilization review, disease management, consultative services, and internet prescription fulfilment. In the 1970s, PBMs began to adjudicate prescription drug claims, and in the 1990s, they introduced online, real-time electronic drug claims processing. Today, PBMs use advanced information technology to establish links with pharmacies to enable two-way communication of claims data and clinical information. The entire claims adjudication process is now paperless.
To ensure that PBMs are complying with contract terms, managing trends, and delivering the expected claims processing and quality of service, plan sponsors must conduct a pharmacy benefit claims audit. This involves testing 100% of the claims to identify systemic adjudication errors or anomalies, such as paying claims for non-covered items and claims payment amounts greater than the contracted amounts. Once the audit report is finalized, the recovery effort begins, which involves recovering any funds that the plan sponsor or the plan's members overpaid and providing corrective action plans to fix errors. Most PBMs have processes in place to conduct impact analyses of all issues found during the audit to identify claims incorrectly processed, provide their findings to plan sponsors, and make financial payments to the plan, if applicable.
Life Insurance: Testing and Privacy
You may want to see also
PBMs can inflate prescription drug costs for insurers and consumers
Pharmacy benefit managers (PBMs) are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. PBMs occupy a central role in the drug price supply chain as negotiators, administrators, and decision-makers about which drugs will be most accessible to consumers. They act as third-party contractors that manage prescription drug benefits for insurers. PBMs create and update formularies of preferred drugs, with different prices and cost-sharing amounts that influence what beneficiaries pay out of pocket and which medications they can access through their insurance.
PBMs negotiate rebates and discounts for an insurance plan from drug manufacturers and determine the prices insurers pay and the payments pharmacies receive. They can profit by capturing portions of the discounts and rebates they negotiate for insurers and pocketing the difference between what insurers pay and pharmacies receive. This practice is known as "spread pricing," and it contributes to higher drug prices for consumers and insurers.
PBMs also have the power to restrict access to medicines. In 2022, the three largest PBMs excluded more than 1,150 medicines from their standard commercial insurance formularies, representing a nearly 1,000% increase since 2014. This includes medicines that would provide patients with needed treatments at lower costs. PBMs may also use utilization management tools, such as requiring prior authorization or failing first on other therapies, which can delay patient access to more affordable treatments.
Additionally, PBMs have been criticized for lacking transparency in their pricing practices. They may keep a portion of the rebates they negotiate rather than passing the full amount to insurers or patients. This lack of transparency makes it challenging to understand the extent to which PBM business practices impact drug costs.
The concentration and vertical integration within the PBM market have led to higher drug prices, affecting consumers, employers, and insurers that don't own a pharmacy benefit manager. PBMs hold significant influence over medication costs, availability, and patient choices, making them central players in the broader debate over prescription drug costs in the United States.
Life Insurance: Geico's Accelerated Rider Option Explained
You may want to see also
Frequently asked questions
Pharmacy Benefit Managers (PBMs) are entities that administer prescription drug insurance benefits.
PBMs act as middlemen between insurance plans, drug manufacturers, and pharmacies. They negotiate prices, establish formularies, and process drug claims.
No, they are not the same. Insurance companies often pay an administrative fee to PBMs for their services.
PBMs make money through administrative fees, mail-order fees, and data sales. They also generate revenue by acquiring rebates from drug manufacturers and retaining a portion of the payment rates they set for insurers and pharmacies.
PBMs can drive up prescription drug costs for consumers and restrict access to medicines. They have been criticized for putting profits before patients' needs.
